Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway

Creative Commons License

Aktepe O. H., Şahin T. K., Güner G., Arik Z., Yalçin Ş.

Turkish journal of medical sciences, vol.51, pp.368-374, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51
  • Publication Date: 2021
  • Doi Number: 10.3906/sag-2005-413
  • Journal Name: Turkish journal of medical sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.368-374
  • Keywords: Lycopene, cervix cancer, cancer treatment, chemotherapy, BREAST-CANCER, NRF2, INHIBITION, RESISTANCE, APOPTOSIS, EXPRESSION, SURVIVAL
  • Open Archive Collection: AVESIS Open Access Collection
  • Hacettepe University Affiliated: No

Abstract

Background/aim: Lycopene is associated with anticancer effects in various tumor types. However, the exact underlying mechanisms of action of lycopene in human cervical cancer remain to be determined. This study aimed to determine anticancer efficacy and mechanism of lycopene in human cervical carcinoma (HeLa) cells.